| Literature DB >> 32398018 |
Swagata Tripathy1,2, Swati P Acharya3, Santosh Singh3, Suravi Patra3,4, Biswa Ranjan Mishra4,5, Nilamadhab Kar6.
Abstract
BACKGROUND: Data on intensive care unit (ICU) related psychiatric morbidity from Low Middle-Income Countries are sparse. We studied the ICU related posttraumatic stress symptoms (PTSS), anxiety, and depression symptoms in a cohort of patients from Eastern India.Entities:
Keywords: Anxiety; Depression; India; Intensive care; Low middle-income countries; Mental health; Outcomes; Posttraumatic stress symptoms; Quality of life
Mesh:
Year: 2020 PMID: 32398018 PMCID: PMC7216410 DOI: 10.1186/s12888-020-02632-x
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Fig. 1STROBE diagram showing the flow of patients in the study
Sample characteristics
| Variable | Total | Male ( | Female ( | |
|---|---|---|---|---|
| Age years mean (95% CI) | 47.8 (46–49.5) | 49 (47–51) | 46 (43–49) | 0.12 |
| Education <6th grade n (%) | 301 (93) | 182 (94) | 119 (92) | 0.13 |
| Married n (%) | 288 (89) | 169 (88) | 49 (89) | 0.31 |
| Have young children < 18 yrs. n (%) | 79 (25) | 43 (22) | 36 (28) | 0.28 |
| Employed n (%) | 125 (39) | 97 (51) | 28 (22) | 0.00 |
| Substance Abuse n (%) | 108 (34) | 75 (39) | 33 (25) | 0.01 |
| Experienced Life Stressors n (%) | 6 (2) | 2 (1.0) | 4 (3) | 0.18 |
| Low Social Support n (%) | 62 (19) | 39 (20) | 23 (18) | 0.65 |
| Indication for ICU stay n (%) | – | – | 0.58 | |
| Postoperative | 117 (36) | |||
| Medical | 101 (32) | |||
| Neurological | 68 (21) | |||
| Trauma | 36 (11) | |||
| Length of Stay in ICU days mean (95% CI) | 4.7 (4.2–5.1) | 4.7 (4.1–5.2) | 4.6 (4.0–5.2) | 0.68 |
| APACHE II mean (95% CI) | 9.5 (9–10) | 9.7 (9.0–10.4) | 9.2 (8.4–9.9) | 0.23 |
| SOFA score mean (95% CI) | 3.4 (3–3.7) | 3.3 (2.9–3.7) | 3.4 (2.8–4.0) | 0.85 |
| Mechanical Ventilation > 48 h n (%) | 169 (53) | 105 (54.7) | 64 (50) | 0.34 |
| RAS scores mean (95% CI) | −0.4(− 0.3to-0.5) | −0.38 (− 0.24 to − 0.5) | −0.47 (− 0.33 to − 0.61) | 0.38 |
| Administered benzodiazepine n (%) | 163 (51) | 99 (51.6) | 64 (49) | 0.68 |
| Administered Steroids n (%) | 145 (45) | 84 (44) | 61 (47) | 0.57 |
| IESr in ICU median (IQR) | 7 (6) | 8(5) | 7 (6) | 0.16 |
| IESr at 1-month median (IQR) | 2 (2) | 2 (2) | 2 (3) | 0.88 |
| IESr at 3 months median (IQR) | 0 (2) | 0 (2) | 0 (2) | 0.87 |
| HADS in ICU median (IQR) | 10 (5) | 10 (4) | 8 (4) | 0.71 |
| HADS at 1-month median (IQR) | 3 (2) | 3 (2) | 3 (3) | 0.95 |
| HADS at 3 months median (IQR) | 2 (3) | 3(3) | 2 (4) | 0.58 |
| EQ5D VAS in ICU | 35 (10) | 35 (10) | 35 (10) | 0.3 |
| EQ5D VAS 30 d | 70 (15) | 70 (11) | 70 (15) | 0.34 |
| EQ5D VAS 90 d | 80 (11) | 80 (15) | 80 (10) | 0.69 |
APACHE Acute Physiology and Chronic Health Evaluation score, SOFA Sequential Organ Failure Assessment, RAS Richmond Agitation Sedation Scale, IES-r Impact of Events Scale-Revised, HADS Hospital Anxiety Depression Scale, IQR Inter Quartile Range, EQ5D VAS Visual Analogue Score in European Quality of Life 5 dimensions tool, d days
Psychiatric morbidity scores over the study period
| Median (IQR) Scores | ||||||
|---|---|---|---|---|---|---|
| Total IES-r | 7 (6) | 5 (4) | 4 (3) | 2 (3) | 0 (2) | 0 (0) |
| Intrusion | 3 (2) | 2 (2) | 1 (1) | 1 (1) | 0 (1) | 0 (0) |
| Hyperarousal | 2 (3) | 2 (2) | 2 (2) | 1 (2) | 0 (1) | 0 (0) |
| Avoidance | 2 (2) | 1 (2) | 0 (1) | 0 (0) | 0 (0) | 0 (0) |
| Total HADS | 10 (5) | 6 (3) | 4 (3) | 3 (2) | 2 (3) | 0 (0) |
| Depression Domain | 7 (3) | 4 (3) | 3 (2) | 2 (3) | 2 (2) | 0 (0) |
| Anxiety Domain | 3 (3) | 2 (2) | 1 (2) | 1 (2) | 0 (1) | 0 (0) |
| EQ5D Index | 0.24 (0.2) | 0.32 (0.4) | 0.65 (0.) | 0.72 (0.1) | 1 (0.2) | 1 (0) |
| VAS EQ5D | 35 (10) | 45 (10) | 60 (15) | 70 (15) | 80 (15) | 95 (5) |
IES-r Impact of Events Scale-Revised, HADS Hospital Anxiety Depression Scale, EQ5D Euro Quality of Life 3 Dimensions, VAS Visual Analogue Scale, IQR Inter Quartile Range. Mentioned as median score (IQR)
Domain wise point prevalence of mental health outcomes at various points of follow up. The numbers are in percentages
| Proportions above cut off point | ||||||
|---|---|---|---|---|---|---|
| 0 | 7 | 14 | 30 | 90 | 180 | |
| Total HADS score > 12 | 72 | 2.7 | 0.6 | 1.2 | 0.9 | 0 |
| HADS Anxiety (subscale score > 7) | 6.3 | 0.3 | 0 | 0 | 0.3 | 0 |
| HADS Depression (subscale score > 7) | 33.2 | 5.4 | 2.7 | 0.9 | 0.9 | 0 |
| PTSS- IES-r (cut off score > 30) | 0.6 | 0 | 0 | 0 | 0.3 | 0 |
Cut off for IES-r total is > 30, and for HADS anxiety and depression, it is > 7 [10, 11]
Results of Logistic Regression for variables affecting mental health outcome scores at 1 and 3 months of ICU discharge
| Variable | B | SE | Wald | df | Sig. | Odds Ratio | 95% CI for OR UPPER | LOWER |
|---|---|---|---|---|---|---|---|---|
| Married | −1.01 | 0.43 | 4.42 | 1 | 0.04 | 0.36 | 0.14 | 0.93 |
| Substance abuse | 1.52 | 0.41 | 13.5 | 1 | < 0.005 | 4.57 | 2.03 | 10.28 |
| Social Support | −0.76 | 0.37 | 3.59 | 1 | 0.04 | 0.5 | 0.22 | 0.9 |
| QOL score at 1 month | −4.21 | 1.09 | 14.5 | 1 | < 0.005 | 0.015 | 0.002 | 0.131 |
| Substance abuse | 0.93 | 0.41 | 5.3 | 1 | 0.02 | 2.5 | 1.15 | 5.68 |
| Comorbidity score | 0.67 | 0.26 | 6.5 | 1 | 0.01 | 1.9 | 1.17 | 3.3 |
| Social Support | - 0.8 | 0.4 | 4.01 | 1 | 0.04 | 0.45 | 0.2 | 0.9 |
| Substance Abuse | 0.64 | 0.27 | 5.79 | 1 | 0.02 | 1.92 | 1.13 | 3.27 |
| APACHE II score | 0.06 | 0.03 | 4.17 | 1 | 0.04 | 1.06 | 1.002 | 1.12 |
| QOL score at 1 month | −3.16 | 0.02 | 11.85 | 1 | 0.001 | 0.04 | 0.007 | 0.25 |
| Substance abuse | 0.73 | 0.28 | 6.59 | 1 | 0.01 | 2.08 | 1.19 | 3.65 |
| Social Support | −0.86 | 0.37 | 5.49 | 1 | 0.02 | 0.42 | 0.2 | 0.86 |
Social Support – Based on scores on the MSPS scale, lower scores indicate less social support. QOL: Quality of Life based on EQ5D- EQ5D 3 L index scores where lower scores indicate worse QOL; Comorbidity score is the Chalrson comorbidity index, with higher scores indicating more significant comorbidity. APACHE II- Acute Physiology and Chronic Health Evaluation scores where lower scores indicate greater severity of illness in the first 24 h of ICU admission; HADS – Hospital Anxiety Depression scale; IES-r – Impact of events scale revised- indicative of symptoms of posttraumatic stress
Estimated fixed effects of predictors of mental health outcome scores
| Parameter | Estimate | df | t | P | 95% CI | ||
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
| 9.11 | 338.09 | 2.65 | < 0.01 | 7.87 | 10.36 | ||
| −0.02 | 316.87 | −2.38 | 0.02 | −0.04 | − 0.00 | ||
| −2.94 | 317.18 | −4.15 | < 0.01 | −4.32 | −1.55 | ||
| 3.82 | 316.76 | 4.37 | < 0.01 | 2.11 | 5.53 | ||
| 0.08 | 317.87 | 2.61 | 0.01 | 0.02 | 0.15 | ||
| −2.24 | 1643.18 | −12.79 | < 0.01 | − 2.59 | − 1.9 | ||
| −3.66 | 1643.18 | −20.89 | < 0.01 | −4.01 | −3.32 | ||
| −5.32 | 1643.18 | −30.33 | < 0.01 | −5.66 | −4.97 | ||
| −6.43 | 1643.18 | −36.69 | < 0.01 | −6.78 | −6.09 | ||
| −7.24 | 1643.18 | −41.06 | < 0.01 | −7.59 | − 6.90 | ||
| 3.76 | 337.9 | 12.45 | < 0.01 | 3.17 | 4.35 | ||
| −1.34 | 315.97 | −4.08 | < 0.01 | − 1.98 | −0.69 | ||
| −1.2 | 1643.03 | −13.98 | < 0.01 | − 1.36 | − 1.03 | ||
| − 1.74 | 1643.03 | −20.37 | < 0.01 | − 1.91 | − 1.58 | ||
| −2.07 | 1643.03 | −24.19 | < 0.01 | − 2.24 | − 1.9 | ||
| − 2.4 | 1643.03 | − 28.04 | < 0.01 | − 2.57 | − 2.23 | ||
| −3.03 | 1643.03 | −35.20 | < 0.01 | −3.2 | − 2.86 | ||
| 6.79 | 356.40 | 22.8 | < 0.01 | 6.21 | 7.38 | ||
| −0.7 | 317.5 | −1.94 | 0.05 | − 1.4 | 0.00 | ||
| −0.43 | 317.09 | −3.36 | < 0.01 | −0.68 | −0.18 | ||
| 0.37 | 316.97 | 2.79 | 0.01 | 0.11 | 0.63 | ||
| −1.89 | 1642.43 | − 17.19 | < 0.01 | −2.11 | − 1.68 | ||
| −3.02 | 1642.43 | −27.39 | < 0.01 | −3.23 | − 2.8 | ||
| −3.98 | 1642.43 | −36.11 | < 0.01 | −4.19 | − 3.76 | ||
| −4.73 | 1642.43 | −42.89 | < 0.01 | − 4.94 | − 4.51 | ||
| −6.3 | 1642.43 | −56.82 | < 0.01 | −6.52 | − 6.08 | ||
EQ5D- EQ5D 3 L index scores, Life Stressor (1)- Stressful life situations present, APACHE II- Acute Physiology and Chronic Health Evaluation scores, Time 2–6- Scores at 7,14,30,90 and 180 days, Benzodiazepines (1)- received benzodiazepines during ICU stay, Sedation (1)- had a mean sedation score < −1 or > 1 on the Richmond Agitation Sedation Scale (signifying over or under sedation respectively)